July 9, 2009 – Coherex Medical Inc. today said its Coherex FlatStent EF PFO Closure System has been granted CE mark clearance for use in Europe and other countries to close patent foramen ovales (...
June 30, 2009 - Stentys this week said it secured the second tranche of its series B financing, which will enable the company to obtain CE marking and begin European marketing of the first self-...
June 24, 2009 – CorNova Inc. said this week it received CE mark approval for its Valecor Platinum Coronary Stent System, a next generation cobalt-chromium bare metal stent.
June 23, 2009 – Abbott said today it received CE mark (Conformite Europeenne) for its next-generation Xience PRIME Everolimus-Eluting Coronary Stent System for the treatment of coronary artery...
June 18, 2009 – Abbott this week initiated SPIRIT PRIME, a clinical trial to study the performance of the company's next-generation Xience PRIME Everolimus-Eluting Coronary Stent System, currently...
June 11, 2009 - Cook Medical announced today the completion of patient enrollment in its REFORM clinical trial, designed to evaluate Cook’s advanced Formula Balloon Expandable Stent for the...
June 8, 2009 - The Bypass Angioplasty Revascularization Investigation With Diabetes Trial (BARI-2D) is a useful and focused trial that builds on the body of scientific knowledge physicians use to...
June 5, 2009 - Raydiance Corp. introduced Smart Light MD — a software-controlled ultrafast laser for manufacturing cardiovascular stents and other medical micro-devices.
June 2, 2009 – During their report Friday at the 63rd Annual Meeting of the Society for Vascular Surgery, Seshadri Raju, M.D., FACS, and other researchers from the University of Mississippi in...
June 1, 2009 - Devax Inc. today said FDA has conditionally approved an investigational device exemption (IDE) for its AXXESS Biolimus A9-Eluting Bifurcation Stent System, allowing the company to...
June 1, 2009 - Six months after placement of a vProtect Luminal Shield to treat a "vulnerable plaque,” a follow-up exam revealed reduced plaque burden and reduced stenosis in the target vessel....
May 28, 2009 - Boston Scientific Corp. said yesterday it received FDA clearance to market its TAXUS Liberte Atom Paclitaxel-Eluting Coronary Stent System, a next-generation drug-eluting stent (DES...
May 26, 2009 – AMG International GmbH last week submitted its second-generation drug-eluting stent (DES), Itrix, for regulatory review in Europe. The stent offers a bioabsorbable polymer that...
May 21, 2009 - Boston Scientific Corp. this week announced results from an analysis of economic and quality of life outcomes, based on one-year data from its landmark SYNTAX trial.
May 22, 2009 - New data presented yesterday at EuroPCR from an international, post-approval, single-arm study show that Abbott's XIENCE V Everolimus Eluting Coronary Stent System demonstrated low...
May 21, 2009 - InspireMD Ltd. said today it completed enrollment for the MAGICAL Trial (MGuard in Acute Myocardial), which is designed to confirm the clinical feasibility, safety and performance...
May 10, 2009 - Medtronic Inc. Friday announced the settlement of all royalty disputes with Johnson and Johnson (J&J) that concern Medtronic’s licensed use of the Palmaz, Schatz and Pinchuk...
May 8, 2009 - Preliminary data presented yesterday at the 32nd annual SCAI Scientific Sessions show that 82 percent of patients treated with Cook Medical’s Zilver PTX drug-eluting peripheral stent...
May 6, 2009 - Spectranetics Corp. yesterday said it made a pre-IDE (investigational device exemption) submission to the FDA regarding the use of laser ablation to treat in-stent restenosis (ISR)...
May 5, 2009 - ITGI Medical Ltd. Said last week the FDA granted HUD (humanitarian use device) designation to Over and Under and Aneugraft pericardium covered stents for treatment of perforations...
April 20, 2009 - Boston Scientific recently disclosed the Court of Appeals for the Federal Circuit upheld the District Court’s decision that Johnson & Johnson’s (J&J) Bx Velocity and...
April 16, 2009 -Twelve-month data from the ZEST trial presented at ACC 2009 showed the Endeavor Drug-Eluting Stent (DES) from Medtronic Inc. was associated with a statistically significant 29...
April 13, 2009 - To improve hospital performance in door-to-balloon (DTB) times nationally, the American College of Cardiology D2B Alliance recently enrolled approximately 1,000 hospitals that...
April 10, 2009 - The results of the ZEST randomized controlled trial released at ACC 2009 showed the Cypher Sirolimus-eluting Coronary Stent significantly outperformed the Endeavor and Taxus...
April 9, 2009 - Researchers say a larger trial is needed to effectively test a novel stent designed to speed arterial healing in heart attack patients by attracting the body’s own circulating...
April 3, 2009 - Long-term data presented at ACC.09 from Abbott’s SPIRIT II clinical trial demonstrated the clinical advantages of the XIENCE V Everolimus-Eluting Coronary Stent continued to...
April 2, 2009 — Abbott yesterday announced the initiation of the MOBILITY clinical trial to study the safety and efficacy of the Absolute Pro Peripheral Self-Expanding Stent System in patients...
April 1, 2009 - Medtronic Inc. this week began the international launch of the Driver Sprint RX Coronary Stent System, which received the CE Mark in February and is planned to be commercially...
March 30, 2009 - An AHRQ-funded study finds a lower risk of death and heart attack in heart disease patients 65 and older who were treated with drug-coated stents to prevent blockages as compared...
March 30, 2009 – Analysis of Boston Scientific’s SYNTAX trial found that while the overall cost effectiveness of percutaneous coronary intervention (PCI) versus coronary artery bypass graft (CABG...
March 24, 2009 - Abbott said today it initiated the next phase of the ABSORB clinical trial to evaluate the safety and performance of the company's fully bioabsorbable drug-eluting coronary stent...
March 19, 2009 - The FDA has approved an investigational device exemption (IDE) for a multicenter clinical trial of IDEV Technologies Inc.’s SUPERA stent, a novel stent platform designed for the...
March 18, 2009 - Flexible Stenting Solutions Inc. (FSS) this week submitted an investigational device exemption (IDE) application to the FDA for its FlexStent Femoropopliteal SE Stent System for...
March 17, 2009 – Twelve-month data from the ATLANTA Trial shows that the CATANIA Coronary Stent System with NanoThin Polyzene-F offers sustained benefit in the treatment of de novo coronary...
March 16, 2009 - Cordis Corp. said today it plans to launch a global, head-to-head, randomized clinical trial called NEVO II, which will compare the NEVO sirolimus-eluting coronary stent to the...
March 13, 2009 - A comprehensive analysis published this week in The Lancet from the ABSORB clinical trial demonstrated that Abbott’s bioabsorbable drug eluting stent (DES), currently in...
March 13, 2009 -Medical device pioneer Stentys said today it extended its self-expanding and disconnectable technology platform to include a second major indication - acute myocardial infarction (...
March 12, 2009 - CeloNova BioSciences Inc. said yesterday physicians performing a live stent implantation during the annual scientific meeting of the Sociedad Venezolana de Cardiologia...
March 10, 2009 - Carotid artery stenting (CAS) has demonstrated outcomes consistent with the American Heart Association’s (AHA) long-established guidelines for treatment of patients who have...
March 5, 2009 - In the first six-year follow-up of a pivotal study of any drug-eluting stent, the clinical benefits of the CYPHER Sirolimus-eluting Coronary Stent compared to a bare-metal stent (...
March 5, 2009 - Prescient Medical Inc. announced it completed enrollment in February of 30 patients in the first phase of its first-in-human clinical trial for the vProtect Luminal Shield,...
February 19, 2009 - C. R. Bard Inc. this week said it received pre-market approval (PMA) from the FDA to market the LifeStent FlexStar and FlexStar XL Vascular Stent Systems, which are approved...
February 19, 2009 - The New England Journal of Medicine this week published the results from the SYNTAX trial, in which percutaneous coronary intervention (PCI) using the TAXUS Express2 Paclitaxel...
February 16 - The CYPHER SELECT Plus Sirolimus-eluting Coronary Stent has received CE marking within the European Union (EU) for treatment of patients with diabetes, a complex and often difficult-...
February 11, 2009 – On Wednesday, Feb. 18, 2009 at 6:30 pm, Shawnee Mission Medical Center (SMMC), Merriam, KS will host an angioplasty stent placement Webcast.
February 10, 2009 - W. L. Gore and Associates today said at the International Congress on Endovascular Interventions XXII the FDA cleared the GORE Flow Reversal System, which minimizes the risk of...
February 9, 2009 - Implantation of drug-eluting stents to treat degenerative in aortocoronary saphenous vein graft (SVG) lesions is safe, according to a study published in the Jan. 15 issue of the...
February 6, 2009 - Boston Scientific Corp. yesterday submitted to the FDA the final modules of the company’s pre-market approval (PMA) applications for both its TAXUS Liberte Atom Paclitaxel-...
February 6, 2009 - Premier Purchasing Partners yesterday announced new agreements for drug-eluting coronary stents with Abbott Laboratories Inc., Abbott Vascular and Cordis Corp.
February 3, 2009 – Medtronic has completed enrollment in PROTECT, the company’s global study comparing its Endeavor drug-eluting stent (DES) to Johnson & Johnson’s Cypher DES.
February 2, 2009 - Boston Scientific Corp. today said it began patient enrollment in the PLATINUM clinical trial, which is designed to evaluate the company’s PROMUS Element Everolimus-Eluting...
January 29, 2009 - Boston Scientific Corp. said today it received approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market its TAXUS Liberte Paclitaxel-Eluting Coronary...
January 28, 2009 - Data published this week in the online journal Circulation from the SPIRIT III U.S. pivotal trial demonstrates that the XIENCE V everolimus-eluting coronary stent system...
January 27, 2009 - According to research findings from Interventional Cardiologist Paul A. Gurbel, M.D., director of the Sinai Center for Thrombosis Research based at Sinai Hospital of Baltimore,...
January 13, 2009 - Micell Technologies, a development-stage biomedical device company dedicated to developing innovative interventional cardiology systems, has obtained the rights to Maxcor's CE-...
December 22, 2008 - C. R. Bard Inc. recently received FDA clearance to market the E-Luminexx Vascular Stent - a flexible, self-expanding nitinol stent.
November 13, 2008 - Medtronic Inc. today started its U.S. market launch of the Endeavor Sprint drug-eluting stent (DES) on a rapid exchange (RX) delivery system.
